Pre-clinical cancer-target validation

Pre-clinical cancer-target validation
Author Information (click to view)

Source: NIH


Source: NIH (click to view)

Source: NIH

Advertisement

Published and unpublished studies by investigators in the pharmaceutical industry indicate that a disturbingly high number of academic laboratories’ reports nominating potential new cancer-drug targets are either non-reproducible or, if reproducible, are not sufficiently robust to form the basis for drug-discovery efforts.

 

Source: NIH

Submit a Comment

Your email address will not be published. Required fields are marked *

three × one =